Literature DB >> 16369291

Hypertriglyceridemia in antiretroviral therapy.

Frank Aiwansoba Imarhiagbe1, Emmanuel Pandy Kubeyinje.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16369291      PMCID： PMC1681638     

Source DB:  PubMed          Journal:  MedGenMed        ISSN： 1531-0132


× No keyword cloud information.
  10 in total

Review 1.  HIV-associated lipodystrophy syndrome.

Authors:  R B Qaqish; E Fisher; J Rublein; D A Wohl
Journal:  Pharmacotherapy       Date:  2000-01       Impact factor: 4.705

2.  Use of fibrates in the management of hyperlipidemia in HIV-infected patients receiving HAART.

Authors:  L Calza; R Manfredi; F Chiodo
Journal:  Infection       Date:  2002-01       Impact factor: 3.553

Review 3.  Insulin resistance in HIV-related lipodystrophy.

Authors:  Nasser Mikhail
Journal:  Curr Hypertens Rep       Date:  2003-04       Impact factor: 5.369

4.  Cardiovascular risk factors and probability for cardiovascular events in HIV-infected patients: part I. Differences due to the acquisition of HIV-infection.

Authors:  T Neumann; T Woiwoid; A Neumann; M Miller; B Ross; L Volbracht; N Brockmeyer; G Gerken; R Erbel
Journal:  Eur J Med Res       Date:  2003-06-30       Impact factor: 2.175

5.  Reversal of atherogenic lipoprotein profile in HIV-1 infected patients with lipodystrophy after replacing protease inhibitors by nevirapine.

Authors:  Eugenia Negredo; Josep Ribalta; Roger Paredes; Raimón Ferré; Guillem Sirera; Lidia Ruiz; Juliana Salazar; Peter Reiss; Lluís Masana; Bonaventura Clotet
Journal:  AIDS       Date:  2002-07-05       Impact factor: 4.177

6.  Differentiating hyperlipidaemia associated with antiretroviral therapy.

Authors:  Stefan Mauss; Juergen Stechel; Reinhard Willers; Guenther Schmutz; Florian Berger; Werner O Richter
Journal:  AIDS       Date:  2003-01-24       Impact factor: 4.177

7.  Lipid profiles in HIV-infected patients receiving combination antiretroviral therapy: are different antiretroviral drugs associated with different lipid profiles?

Authors:  E Fontas; F van Leth; C A Sabin; N Friis-Møller; M Rickenbach; A d'Arminio Monforte; O Kirk; M Dupon; L Morfeldt; S Mateu; K Petoumenos; W El-Sadr; S de Wit; J D Lundgren; C Pradier; P Reiss
Journal:  J Infect Dis       Date:  2004-03-02       Impact factor: 5.226

8.  Cardiovascular disease risk factors in HIV patients--association with antiretroviral therapy. Results from the DAD study.

Authors:  Nina Friis-Møller; Rainer Weber; Peter Reiss; Rodolphe Thiébaut; Ole Kirk; Antonella d'Arminio Monforte; Christian Pradier; Linda Morfeldt; Silvia Mateu; Matthew Law; Wafaa El-Sadr; Stephan De Wit; Caroline A Sabin; Andrew N Phillips; Jens D Lundgren
Journal:  AIDS       Date:  2003-05-23       Impact factor: 4.177

Review 9.  Lipid profiles associated with antiretroviral drug choices.

Authors:  Marc van der Valk; Peter Reiss
Journal:  Curr Opin Infect Dis       Date:  2003-02       Impact factor: 4.915

10.  Fat distribution and metabolic abnormalities in HIV-infected patients on first combination antiretroviral therapy including stavudine or zidovudine: role of physical activity as a protective factor.

Authors:  Pere Domingo; María A Sambeat; Antonio Pérez; Jordi Ordoñez; José Rodriguez; Guillermo Vázquez
Journal:  Antivir Ther       Date:  2003-06
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.